Who Owns ECMOHO Company?

Who Owns ECMOHO?

Understanding the ownership structure of a company like ECMOHO is crucial, as it provides insights into its strategic direction, influence, and accountability. A pivotal event for ECMOHO was its listing on the NASDAQ in 2019, which transformed its ownership from a privately-held entity to one with public shareholders. ECMOHO Limited, founded in December 2011 by Zoe Wang and Leo Zeng, is headquartered in Shanghai, China.

ECMOHO operates as a digital healthcare marketing and supply chain platform in China, connecting pharmaceutical companies and healthcare providers with online and offline channels. It provides integrated solutions for product commercialization and distribution, leveraging technology and data analytics. As of 2025, ECMOHO continues to focus on health and wellness, beauty, and household products, demonstrating its market position in China's e-commerce landscape.

Delving into ECMOHO company ownership details reveals a dynamic landscape shaped by its founders, early investors, and the public market following its 2019 NASDAQ debut. The journey from a privately held startup to a publicly traded entity significantly altered its ECMOHO stock ownership. Examining the ECMOHO company ownership structure provides a clearer picture of who holds influence and how decisions are made within the organization. This exploration into ECMOHO's corporate ownership details is key for anyone interested in ECMOHO investor relations or understanding the company's financial ownership details.

The founders, Zoe Wang and Leo Zeng, established ECMOHO in December 2011, laying the groundwork for its future growth. Their initial stakes formed the bedrock of the company's ownership before external investment and public trading. The company's vision was to bridge brand owners and Chinese consumers in the non-medical health and wellness market, a sector that has seen significant expansion. ECMOHO generated revenues primarily through product sales to consumers and retailers, with total net revenues reaching between US$329 million and US$330 million in 2019, an increase of approximately 65% to 66% year-over-year. Understanding the ECMOHO ownership history is vital to appreciating its current standing.

Following its listing on the NASDAQ, ECMOHO became a publicly traded entity, meaning its ownership is distributed among a broad base of shareholders. This transition signifies that no single entity or individual may hold a majority stake, making it important to identify the key stakeholders in ECMOHO. The ECMOHO company beneficiaries are now diverse, encompassing institutional investors, retail investors, and potentially employee stock ownership plans. The question of who is the majority shareholder of ECMOHO can change over time based on market activity and investment strategies.

The company's operational focus remains on health and wellness, beauty, and household products, showcasing its strategic market positioning. For those seeking to understand who controls ECMOHO operations, examining the board of directors and major institutional shareholders is paramount. The ECMOHO management ownership also plays a significant role in the company's direction. Analyzing the ECMOHO business ownership information helps in understanding the broader financial ownership details and the company's overall trajectory. For instance, understanding the ECMOHO BCG Matrix can provide insights into the performance of its product portfolio, which is directly influenced by its ownership and strategic decisions.

The journey of ECMOHO began in December 2011, with Ms. Zoe Wang and Mr. Leo Zeng establishing its precursor, Shanghai ECMOHO Health Biotechnology Co., Ltd., under the laws of the People's Republic of China. This foundational step laid the groundwork for what would become a significant entity in its sector.

The company's early growth was fueled by strategic investments. In August 2015, 'Round A Investors' injected a total of US$13,081,880 into ECMOHO Shanghai, acquiring a 19% equity stake that came with preferential rights. This was followed by a substantial 'Round B' investment in April 2016, where investors contributed US$24,000,000 for a 12% equity interest, also with preferential terms. These early funding rounds were crucial in shaping the ECMOHO company ownership structure.

These initial investment agreements were meticulously crafted to safeguard investor interests and align with the company's long-term objectives. Key provisions included preferential rights in the event of liquidation, with Round B Investors having priority over Round A Investors, and both groups being entitled to 150% of their initial investment plus any declared but unpaid dividends. Furthermore, investors were granted 'put' rights, enabling them to sell their equity back under specific circumstances, such as a material breach of contract or if a public listing was not achieved by August 2021. This structure highlights the early focus on investor protection and a clear path towards potential public market access, influencing ECMoho stock ownership dynamics.

Founding Team

ECMoho was founded in December 2011 by Ms. Zoe Wang and Mr. Leo Zeng.

Initial Legal Structure

Its predecessor, Shanghai ECMOHO Health Biotechnology Co., Ltd., was established under PRC laws.

Round A Investment

In August 2015, US$13,081,880 was contributed for a 19% equity interest with preferential rights.

Round B Investment

In April 2016, US$24,000,000 was invested for a 12% equity interest with preferential rights.

Liquidation Preferences

Investors had preferential rights in liquidation, with Round B investors prioritized over Round A investors.

Investor Put Rights

Investors held 'put' rights, allowing them to sell equity back under specific conditions, including failure to list publicly by August 2021.

By July 2018, a significant shift in ECMoho ownership occurred when ECMOHO (Hong Kong) Health Technology Limited, a subsidiary of the Cayman Islands-incorporated ECMOHO Limited, acquired a substantial 97.5% equity interest in ECMOHO Shanghai from its co-founders and other existing shareholders. This move consolidated control under a new parent company structure, impacting the overall ECMoho company ownership structure and potentially influencing ECMoho investor relations.

Key Ownership Transition

In July 2018, ECMOHO (Hong Kong) Health Technology Limited acquired 97.5% of ECMOHO Shanghai's equity. This marked a significant change in ECMoho company ownership structure.

• Founders: Ms. Zoe Wang and Mr. Leo Zeng
• Predecessor Company: Shanghai ECMOHO Health Biotechnology Co., Ltd.
• Round A Investment: US$13,081,880 for 19% equity (August 2015)
• Round B Investment: US$24,000,000 for 12% equity (April 2016)
• Acquiring Entity (July 2018): ECMOHO (Hong Kong) Health Technology Limited
• Acquisition Stake: 97.5% of ECMOHO Shanghai

ECMoho Limited's journey as a publicly traded entity began with its initial public offering (IPO) on November 8, 2019, on the NASDAQ Global Market under the ticker symbol 'MOHO'. This event saw the company offer 4,375,000 American Depositary Shares (ADSs) at US$10.00 per ADS, successfully raising US$43.75 million before accounting for any over-allotment options. Each ADS represents four Class A ordinary shares, a detail crucial to understanding the company's ownership structure. The net proceeds from this offering, after deducting underwriting discounts, commissions, and other associated expenses, amounted to approximately US$35.0 million. This IPO marked a significant step in broadening the ECMoho ownership base.

The ownership landscape of ECMoho has seen some evolution since its public debut. As of March 31, 2025, institutional ownership appears concentrated, with Rhumbline Advisers identified as the sole institutional owner, holding 3,780 shares of ECMoho Ltd - ADR (US:MOHO). While this figure might seem small, it's important to note that SEC filings can reveal a broader spectrum of major shareholders, including individual investors, mutual funds, hedge funds, and other institutions. A key aspect influencing ECMoho company ownership structure is its dual-class share system. As of December 31, 2020, the company had 69,361,833 Class A ordinary shares and 71,355,616 Class B ordinary shares outstanding. This structure is designed to concentrate voting power, meaning that while the shareholder base has expanded, control can remain centralized with specific entities holding the Class B shares.

Understanding who owns ECMOHO involves looking beyond just the number of shares. The dual-class share structure is a critical factor in determining who controls ECMOHO operations. Typically, Class B shares carry superior voting rights compared to Class A shares, allowing holders of Class B shares to exert greater influence over corporate decisions, even if they hold a smaller percentage of the total equity. This means that identifying the holders of Class B shares is key to understanding ECMoho's corporate ownership details and who the key stakeholders in ECMOHO truly are. The company's investor relations information would provide further clarity on management ownership and overall ECMoho financial ownership details.

Key Ownership Insights

ECMoho's ownership is shaped by its dual-class share structure, impacting voting power significantly. The company is publicly traded, making its stock ownership accessible through filings.

• IPO completed on November 8, 2019, raising US$43.75 million.
• Limited identified institutional ownership as of March 31, 2025.
• Dual-class share structure centralizes control.
• Understanding ECMoho company ownership structure requires examining both share classes.

The current board of directors for ECMOHO is comprised of key leadership figures and independent members. Ms. Zoe Wang serves as the Chairperson of the Board and Chief Executive Officer, overseeing the company's strategic direction. Mr. Leo Zeng holds the positions of Acting Chief Financial Officer, Chief Operating Officer, and Director, managing critical financial and operational aspects. Mr. Daniel Wang functions as the General Manager of New Business and a Director, focusing on growth initiatives. The board also includes independent directors Grace Fu and Yuan Fang, who provide external oversight and governance.

ECMoho's ownership structure is characterized by a dual-class share system, which significantly influences voting power. Holders of Class A ordinary shares are granted one vote per share, while holders of Class B ordinary shares possess ten votes per share. As of April 15, 2021, Ms. Zoe Wang and Mr. Leo Zeng were the beneficial owners of all issued and outstanding Class B ordinary shares. These Class B shares represented approximately 49.3% of the total issued and outstanding share capital but accounted for a substantial 90.7% of the aggregate voting power. This arrangement provides the founders with considerable control over corporate decisions, even without holding a majority of the equity. This structure can impact the influence of other shareholders, including public investors, on company matters and potentially affect change of control transactions. There have been no recent public reports of proxy battles or activist investor campaigns directly impacting ECMOHO's governance structure in 2024-2025.

Understanding the ECMoho company ownership structure is crucial for investors seeking to comprehend who controls ECMOHO operations. The dual-class share system, where Class B shares carry ten times the voting power of Class A shares, concentrates significant voting power in the hands of a few key individuals, namely Ms. Zoe Wang and Mr. Leo Zeng, who beneficially owned all Class B shares as of April 15, 2021. This arrangement means that while they may not hold a majority of the equity, their voting power allows them to heavily influence corporate decisions. This aspect of ECMoho stock ownership is a key consideration for anyone analyzing ECMoho shareholders and ECMoho business ownership information. For a deeper dive into the company's journey, you can explore the Brief History of ECMOHO.

Key Governance Insights

ECMoho's governance is heavily influenced by its dual-class share structure. This system grants disproportionate voting power to Class B shareholders, primarily the founders.

• Class B shares have 10 votes per share, while Class A shares have 1 vote per share.
• As of April 15, 2021, Class B shares represented 90.7% of total voting power.
• This structure centralizes control with key management figures.
• It can limit the influence of other shareholders on corporate decisions.

In recent years, ECMOHO has navigated significant shifts in its market presence and financial structure. A key development was the August 2021 announcement of a public offering, intending to raise US$9 million through 10 million American Depositary Shares (ADSs) at US$0.90 each. These funds were earmarked for enhancing its SaaS platform and general corporate purposes. However, the company encountered challenges maintaining its listing on the NASDAQ. By September 2021, it received a notice regarding minimum bid price non-compliance, as its closing bid price remained below US$1.00 for 30 consecutive business days. This led to a transfer of its ADSs listing from the Nasdaq Global Market to the Nasdaq Capital Market in March 2022, providing an additional 180 days to meet compliance requirements. Ultimately, by September 2022, ECMOHO Limited (OTCPK:MOHO.Y) was delisted from the NASDAQ Composite Index. Current publicly available information as of mid-2025 indicates that the company's ADSs are traded on the OTC Markets.

The ownership trends for ECMOHO demonstrate a transition from a NASDAQ-listed entity, which typically has more diverse institutional ownership, to a company trading on OTC markets. This move often correlates with reduced liquidity and transparency. While specific details regarding founder dilution or the emergence of significant new strategic investors in 2024-2025 are not extensively documented in public records, the shift to OTC trading suggests potential difficulties in sustaining the broad public shareholder base characteristic of major stock exchanges. Despite these changes, the company continues to expand its digital marketing initiatives and forge partnerships, such as with Vitamin World, to strengthen its market position and customer loyalty within China's health and wellness sector. This strategic focus aligns with the company's broader Growth Strategy of ECMOHO.

The shift in ECMOHO's trading venue from a major exchange to the OTC markets signifies a change in its investor profile and market accessibility. This transition can influence ECMOHO stock ownership dynamics, potentially leading to a more concentrated group of shareholders or a different type of investor base compared to its NASDAQ-listed period. Understanding who owns ECMOHO in this new environment requires looking at the typical characteristics of OTC-traded companies, which may include less stringent reporting requirements and potentially lower trading volumes, impacting ECMOHO investor relations and overall ECMOHO corporate ownership details.

ECMoho Ownership Structure Changes

The company's move to OTC markets suggests a potential recalibration of its ECMOHO company ownership structure. This often occurs when a company faces challenges meeting major exchange listing requirements.

ECMoho Shareholder Base Evolution

The transition from NASDAQ to OTC markets can alter the composition of ECMOHO shareholders. Information on who is the majority shareholder of ECMOHO may become less transparent.

ECMoho Public Listing Status

As of mid-2025, ECMOHO is no longer listed on the NASDAQ Composite Index. The question of 'Is ECMOHO publicly traded' is answered by its current trading on OTC Markets.

ECMoho Business Ownership Information

The current ECMOHO business ownership information reflects a company adapting to new market conditions. Details on who controls ECMOHO operations are crucial for understanding its strategic direction.